Spdr Series Trust Spdr S&P Pharmaceuticals Etf Newsroom

Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies

Seeking Alpha03:58

These Stocks Are Expected to See at Least 25% Revenue Growth in 2025 – Wolfe

Seeking Alpha03:09

Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside

Benzinga03:06

Unpacking the Latest Options Trading Trends in Merck & Co

Benzinga03:00

Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million

Benzinga01:31

FDA Issues Draft Guidance on Developing Weight Loss Drugs

Seeking Alpha00:53

Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not

Seeking Alpha00:17

Merck & Compnay and OPKO Health Shares Are Trading Higher After the Companies Announced a License and Collaboration Agreement to Develop an Epstein-Barr Virus Vaccine.

Benzinga00:15

Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns

Seeking Alpha00:12

J&J Rybrevant/Lazcluze Combo Bests AstraZeneca's Tagrisso in NSCLC

Seeking AlphaJan 7 23:27

Eli Lilly's Options: A Look at What the Big Money Is Thinking

BenzingaJan 7 22:45

Bristol Late-stage Trial of Opdivo for Head and Neck Cancer Meets Endpoint

Seeking AlphaJan 7 21:43

Johnson & Johnson Announces RYBREVANT Plus LAZCLUZE Show Statistically Significant And Clinically Meaningful Improvement In Overall Survival Versus Osimertinib; Median Overall Survival Improvement Expected To Exceed One Year; First And Only Regimen...

BenzingaJan 7 21:16

Bird Flu Claims First U.S. Life in Louisiana

Seeking AlphaJan 7 06:22

FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development

Seeking AlphaJan 7 01:52

Merck to Buy Vaccine Plant From WuXi Biologics: Report

Seeking AlphaJan 7 00:24

Citi's Recommended List of Large-cap Stocks: GOOGL, STZ, DAL, and More

Seeking AlphaJan 6 23:39

Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart

Seeking AlphaJan 6 23:00

WUXI BIO has once again divested overseas Assets! Merck takes over WUXI BIO's Ireland vaccine factory for 0.5 billion USD | Quick read announcement.

① WUXI BIO announced today that it will sell the Ireland vaccine factory to Merck for 0.5 billion USD; ② this vaccine factory was originally built to undertake Merck's vaccine contract manufacturing business; ③ not long ago, WUXI APPTEC also divested its WuXi ATU business in the USA and United Kingdom.

cls.cnJan 6 22:47

Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study

BenzingaJan 6 21:52